NEW YORK – WEBWIRE – Monday, June 16, 2025
Blackstone (NYSE: BX) announced today that Joseph Cassanelli, former Co-Head of LazardÂ’s U.S. Financial Institutions...
Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced that Novartis...
Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of...